肺高血压的诊断评估:对初级保健医生的综合方法
Suneesh Anand1, Ahmed Sadek1, Anjali Vaidya1
1Department of Medicine, Temple Heart and Vascular Institute, Pulmonary Hypertension, Right Heart Failure, CTEPH Program, Temple University Hospital, Philadelphia, PA 19140, USA.
Journal of clinical medicine
|December 9, 2023
概括
肺高血压 (PH) 是一种严重的心脏病,需要更新诊断标准和早期检测工具. 在专门中心及时诊断和治疗改善了患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 这是右心脏衰竭.
背景情况:
- 肺高血压 (PH) 是一种复杂的疾病,具有多种潜在原因.
- 它代表了右心力衰竭的关键形式,具有显著的死亡率.
- 准确及时的诊断对于有效的管理至关重要.
研究的目的:
- 强调更新PH的诊断标准的重要性.
- 突出多模式诊断工具在PH识别中的作用.
- 倡导简化向专业PH中心的转诊,以获得最佳的患者护理.
主要方法:
- 对PH目前的诊断方法的审查和综合.
- 讨论多模式诊断工具 (例如心声回声,右心导管).
- 强调综合诊断策略.
主要成果:
- 新的诊断标准有助于更早,更准确地识别PH.
- 多模式工具提高了诊断的准确性.
- 早期转诊途径可以改善获得专业护理的机会.
结论:
- 实施修订的PH诊断标准至关重要.
- 综合诊断方法是识别这种危及生命的疾病的关键.
- 在认可中心及时干预可以优化PH患者的预后.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
188
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
188
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Pulmonary Function Tests
335
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
335
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
174
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
174
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
161
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
161


